Literature DB >> 1582271

Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction.

J E Adams1, B A Siegel, J A Goldstein, A S Jaffe.   

Abstract

To determine the frequency and etiology of elevations of CK-MB in patients with pulmonary emboli, we studied 52 patients with well-documented emboli and the absence of known ischemic heart disease or ECG changes suggestive of acute infarction. All patients were evaluated with serial CK-MB determinations at 8-h intervals. All patients with elevations of CK-MB had noninvasive cardiac evaluations. Four (7.7 percent) of the 52 patients had a rising and falling pattern of CK-MB that satisfied enzyme criteria of acute infarction. Three of these four also manifested classic echocardiographic features of right ventricular infarction. None of the four had evidence of left ventricular regional wall motion abnormalities or dysfunction. Of the 48 patients without elevations of CK-MB, only two had segmental right ventricular dysfunction. These findings suggest that pulmonary emboli can induce right ventricular infarction in some (7.7 percent) patients even when patients with a history of coronary artery disease and/or ECG changes of infarction are excluded. Conversely, the diagnosis of pulmonary embolism should be considered in patients when right ventricular infarction is diagnosed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582271     DOI: 10.1378/chest.101.5.1203

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  High dose and short-term streptokinase infusion in patients with pulmonary embolism: prospective with seven-year follow-up trial.

Authors:  C Jerjes-Sanchez; A Ramirez-Rivera; R Arriaga-Nava; S Iglesias-Gonzalez; P Gutierrez; C Ibarra-Perez; A Martinez; S Valencia; A Rosado-Buzzo; J A Pierzo; E Rosas
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

2.  Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

Review 3.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

4.  Acute ECG ST-segment elevation mimicking myocardial infarction in a patient with pulmonary embolism.

Authors:  Tomaž Goslar; Matej Podbregar
Journal:  Cardiovasc Ultrasound       Date:  2010-11-24       Impact factor: 2.062

Review 5.  Right ventricular myocardial infarction and pulmonary embolism differential diagnosis--a challenge for the clinician.

Authors:  Carmen Ginghina; Geana-Alina Caloianu; Marinela Serban; Dinu Dragomir
Journal:  J Med Life       Date:  2010 Jul-Sep

6.  Management of massive and nonmassive pulmonary embolism.

Authors:  Vishal Sekhri; Nimeshkumar Mehta; Naveen Rawat; Stuart G Lehrman; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.